Four House committee bills seek to create tax benefits for biotechs developing infectious disease treatments

As the COVID-19 pandemic makes clear the need for innovative therapies to treat infectious diseases, a trio of Republicans on the House Ways and Means Committee introduced a

Read the full 280 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE